Companies Cryptocurrencies
Anchiano Therapeutics Ltd
Anchiano Therapeutics Ltd
Exchange: NasdaqCM
IPO Date: 14/08/2012
CEO: Dr. Frank G. Haluska
Biotechnology Healthcare 🔗
  • ANCN
  • price
  • market cap
  • changes
If you bought

shares of Anchiano Therapeutics Ltd (ANCN) on
You would have made
Old Price $12 Current Price $12

Anchiano Therapeutics Ltd, formerly known as ABioCancell Therapeutics Inc, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search and destroys paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Address: 1/3 High-Tech Village Givat Ram PO Box 45032 JERUSALEM 02139

Stay updated.